Product Images Leflunomide

The text is describing the results of a clinical trial evaluating the percentage of patients who achieved ACR 20 response at the endpoint. The trial has been divided into two parts, Trial 1 and Trial 2, and the patients have been treated with different drugs such as Leflunomide, Methotrexate, and Placebo. The data shows the response rate of the patients after two months and six months of treatment.*

This appears to be a table or a graph and is not available as readable text.*

This is a label for Leflunomide Tablets, USP that are available in packages of 30 tablets. The tablets contain leflunomide USP (10mg) and the package insert contains the complete prescribing information. The tablets are to be stored at 20° to 25°C (68° to 77°F), which is normal room temperature, and protected from light, and should be kept in a tight container out of reach of children. The product is of Taiwanese origin, manufactured by Cadila Healthcare Ltd., India and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ 08534.*

This is a description for a medication called Leflunomide. Each film-coated tablet contains an unspecified amount of Leflunomide. The medication is stored at 20° to 25°C (68° to 77°F) and should be protected from light. The tablets are manufactured by Cadila Healthcare Ltd. and packed in a tight container with the warning to keep all drugs out of the reach of children. The label also includes a branding for Zydus Pharmaceuticals Inc. with additional codes and numbers that are not clear.*